Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Public Parks in the USA - 26 Famous Cell phone Brands All over The Planet
- 3WHO issues guidance on GLP-1 drugs for obesity
- 4Brazil's agricultural research agency gets cannabis research greenlight
- 5Man who grabbed Ariana Grande at 'Wicked: For Good' premiere also rushed Katy Perry onstage this year. Who is he and why is he doing this?
- Black Friday Paramount+ deal: Save 50% and stream these buzzy Taylor Sheridan shows
- 5 High Limit Outer Hard Drives For Information Stockpiling
- Top Breakfast Food: What's Your Morning Enjoyment?
- The Best Cell phone Brands for Tech Lovers
- Rediscovering Euphoria: Individual Accounts of Conquering Despondency
- Last Christmas, 3 million viewers watched a Chiefs love story — will Bills fans fall just as hard this year?
- Bold Colors, Playful Shapes, Handmade Textures: This Mexico City Home Is 100% Joyful!
- Step by step instructions to Show Children the Significance of Appropriate Handshaking
- AstraZeneca to invest $2 billion as part of US manufacturing push
